Understand the source comparison
Quickcomparison
Dose Range Ganirelix 250 mcg–500 mcg micrograms Cetrorelix 0.25 mg–3 mg mg Frequency Once daily Administration Subcutaneous injection Cycle Length Ongoing/indefinite Onset Speed Moderate (1-2 weeks) Evidence Level Strong human trials (Phase 3 or FDA approved)
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Dose Range
- Ganirelix
- 250 mcg–500 mcg micrograms
- Cetrorelix
- 0.25 mg–3 mg mg
- Frequency
- Once daily
- Administration
- Subcutaneous injection
- Cycle Length
- Ongoing/indefinite
- Onset Speed
- Moderate (1-2 weeks)
- Evidence Level
- Strong human trials (Phase 3 or FDA approved)
- Efficacy